Pharmafile Logo

Personalised medicine: driving a need for greater diversity in clinical trials

Kate Shaw, Innovative Trials’ Founder & CEO, investigates one of the biggest challenges facing clinical research today.

“Recruiting targeted and diverse patient populations into clinical trials has never been more important to ensure robust efficacy and safety data”

Kate Shaw, Innovative Trials‘s Founder & CEO, features in the latest Bioscience Today’s issue, read more here

This content was provided by Innovative Trials

Company Details

 Latest Content from  Innovative Trials 

Retention Patch Program

A partnership between Innovative Trials and the non-profit Oliver Patch Project to boost retention in pediatric studies

Innovative Trials recognised at the PMEA Awards 2023 Gala Dinner

Global patient recruitment Innovative Trials took part of the PMEA Awards gala dinner alongside the best players in the pharmaceutical industry.

Innovative Trials launches the Retention Patch Program

Innovative Trials has unveiled a new partnership with the non-profit Oliver Patch Project to boost retention in pediatric studies.

Innovative Trials at the 2023 Lloyds Bank British Business Excellence Awards

Innovative Trials achievements recognized at the Lloyds Bank British Business Excellence Awards

Innovative Trials has been shortlisted in the PMEA Awards

Innovative Trials finalist in the Support Agency of the Year at the annual PMEA industry awards.

A New Era in Patient Recruitment & Retention

Innovative Trials launches ‘first of its kind’ service to boost clinical trial patient recruitment and retention .

Navigator - Revolutionize your patient recruitment and retention

Welcome to the new era in patient recruitment and retention

Innovative Trials partner with Great Ormond Street Hospital Children’s Charity

The patient recruitment company has chosen their UK charity partner for 2022/2023